Nile Pharmaceuticals and Chemical Industries

Last Updated:
  • 32.10 EGP
  • 0.11
  • 0.34%
النيل للادوية والصناعات الكيماوية - النيل
النيل للادوية
Symbol : NIPH
ISIN : EGS38331C012
52-Week Range : 19.30 - 38.91
Turnover Ratio : 0.28
Market : Egyptian Exchange
Sector : Health Care & Pharmaceuticals
Industry : Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :

Nile Pharmaceuticals and Chemical Industries-Nile Profile

Basic Information

  • Activity :
    Nile Pharmaceuticals and Chemical Industries-Nile (known as: Nile Pharmaceuticals) is a public company, listed on Egyptian Exchange (EGX) since February 1995. Nile Pharmaceuticals operates within the pharmaceuticals,...
  • Industry Group :
    pharmaceuticals Research and Biotechnology
  • Sub-Industry :
  • ISIN :
    EGS38331C012
  • Contact Person :
  • Established On:
    01-Jan-1991
  • Stock Listing On :
    27-Feb-1995
  • No of Employees :
    1,861 Employees as of 2021
  • Outstanding Shares :
    10,125,000
  • Free Float Shares :
  • Par Value :
  • Paid Capital :
  • Market Cap :
    323.90 M EGP
  • Authorized Capital :

Indices Membership

Action Date Index Provider
Join 2020 Health Care & Pharmaceuticals Egyptian Exchange
Leave 2014 EGX 100 Egyptian Exchange
Leave 2014 EGX 70 Egyptian Exchange
Join 1995 Egyptian Exchange
Nile Pharmaceuticals and Chemical Industries-Nile
El Sawah Sq., El Amiriyah, Cairo
T : +20 2 22571725
F : +20 2 22561221
nile-pharm-eg@yahoo.com

Management

Title Name As Of
Chairman: Abdul Rahman Ali 2015
Managing Director: Khaled Hagag 2015
Board Member: Yasser Shaheen 2021
Nevin Abdo 2021
Hisham Danana 2015
Mohamed Mohamed

Reports

Date Title File
Nile Pharmaceuticals Quarterly Financials Report Q1 2021
Nile Pharmaceuticals Quarterly Financials Report Q3 2020
Nile Pharmaceuticals Quarterly Financials Report Q2 2020
Nile Pharmaceuticals Quarterly Financials Report Q1 2020
Nile Pharmaceuticals Annual Financials Report 2019
Nile Pharmaceuticals Quarterly Financials Report Q3 2019
Nile Pharmaceuticals Quarterly Financials Report Q2 2019
Nile Pharmaceuticals Quarterly Financials Report Q1 2019
Nile Pharmaceuticals Annual Financials Report 2018
Nile Pharmaceuticals Quarterly Financials Report Q3 2018
Nile Pharmaceuticals Quarterly Financials Report Q2 2018
Check our coverage for Egypt